Dow Falls More Than 500 Points
b"Plus: Shares of Eli Lilly and Novo Nordisk decline as competition in the anti-obesity drug market ramps up. After the bell, Netflix reported stronger revenue, but said subscriber growth in the current quarter will be weaker than a year ago. J.R. Whalen reports.\\n\\n\\n\\nSign up for the WSJ's free What's News newsletter.\\n\\nLearn more about your ad choices. Visit megaphone.fm/adchoices"